Type 2 Inflammation News

News

Treatment Produces Rapid, Sustained Response in Multiple Type 2 Inflammatory Diseases

09/20/2022

Patients with atopic dermatitis, asthma, or chronic rhinosinusitis with nasal polyps saw clinically meaningful improvements in their disease after treatment with a humanized monoclonal antibody.

Patients with atopic dermatitis,...

09/20/2022

First Report Managed Care

News

Type 2 Inflammation-Specific Agents Ease Asthma Exacerbations

08/25/2022

Jolynn Tumolo ;

An analysis showed agents that target interleukins are significantly associated with reduced rates of asthma exacerbation for patients with severe disease.

An analysis showed agents that...

08/25/2022

First Report Managed Care

News

Monoclonal Antibody Reduces Type 2 Inflammation in Pediatric Patients With AD

08/17/2022

Maria Asimopoulos ;

Biomarkers indicative of type 2 inflammation were significantly reduced in patients receiving a monoclonal antibody compared to those treated with placebo.

Biomarkers indicative of type 2...

08/17/2022

First Report Managed Care

News

Drugs Targeting Type 2 Inflammation May Aid Skin Barrier Function in Atopic Dermatitis

06/07/2022

Jolynn Tumolo ;

Investigators studied the effect of systemic treatments targeting type 2 inflammatory pathways on skin barrier dysfunction in atopic dermatitis.

Investigators studied the effect...

06/07/2022

First Report Managed Care

News

Eosinophilic Esophagitis Symptoms Improved by Monoclonal Antibody Therapy

02/25/2022

Jolynn Tumolo ;

Patients receiving treatment with a monoclonal antibody for asthma, atopic dermatitis, and nasal polyps also saw improvements in concomitant eosinophilic esophagitis symptoms, according to a retrospective chart review.

Patients receiving treatment...

02/25/2022

First Report Managed Care

News

Severe Asthma Exacerbation Rates Appear Lower With Dupilumab Than Other Biologics

02/24/2022

Jolynn Tumolo ;

Authors of an indirect treatment comparison found that dupilumab improved asthma severity more than other biologics such as benralizumab and omalizumab.

Authors of an indirect treatment...

02/24/2022

First Report Managed Care

News

Dupilumab Improves Symptoms in Patients With Severe CRSwNP and Comorbid Asthma

10/27/2021

Jolynn Tumolo ;

“In the difficult-to-treat population of patients with [chronic rhinosinusitis with nasal polyps] with comorbid asthma, the results presented here illustrate that dupilumab as an add-on to the standard-of-care mometasone furoate nasal spray...

“In the difficult-to-treat...

10/27/2021

First Report Managed Care

News

Treatment Shows Benefit for Asthma With Comorbid Perennial Allergic Rhinitis

10/22/2021

Jolynn Tumolo ;

"Dupilumab improved key asthma-related outcomes, suppressed type 2 inflammatory biomarkers, and improved rhinoconjunctivitis-related quality of life in patients with uncontrolled, moderate-to-severe asthma and comorbid PAR,” researchers wrote.

"Dupilumab improved key...

10/22/2021

First Report Managed Care

News

Monthly Dupilumab Effective for Moderate-to-Severe Atopic Dermatitis, Study Suggests

09/14/2021

Jolynn Tumolo ;

According to new findings, over 80% of patients taking dupilumab achieved at least a 50% decrease on the Eczema Area and Severity Index between baseline and week 16.

According to new findings, over...

09/14/2021

First Report Managed Care

News

Implementing Best Practices for AD Can Benefit Patients, Providers

08/18/2021

Julie Gould ;

According to new research findings, global best practices for atopic dermatitis can contribute to the efficacy of treatment, impact health care provider efficiency, and improve costs for health care systems.

According to new research...

08/18/2021

First Report Managed Care

Current Issue

September 2024

Volume 21

Issue 3

Current Issue

Issue Archive

What's Trending?

News

Flu Vaccine Lowers CV Risk for Patients with Type 2 Diabetes

07/29/2016

Patients with type 2 diabetes, who received the flu vaccine, experienced reduced rates of hospitalization for specific cardiovascular events, according to a new study.

Patients with type 2 diabetes,...

07/29/2016

First Report Managed Care

News

Private Insurance Linked to Better ART Adherence in Young Adults Born to Women With HIV

10/05/2022

Jolynn Tumolo ;

Researchers determined the association between insurance type and HIV outcomes, including antiretroviral adherence and health-related quality of life.

Researchers determined the...

10/05/2022

First Report Managed Care

Pharmaceutical Companies Losing Patent Exclusivities

02/21/2012

Tim Casey ;

Since the US Food and Drug Administration approved Lipitor (atorvastatin) in the late 1990s, Pfizer, Inc, could rely on the cholesterol-lowering drug to generate billions in revenue. The product became the best-selling drug in history,...

Since the US Food and Drug...

02/21/2012

First Report Managed Care

News

J&J, Bayer’s Xarelto Curbs Clots, Raises Risk of Bleeding

04/06/2011

First Report Managed Care

News

New Strategies for Treating Diabetes

07/12/2012

First Report Managed Care

Video Insights

Videos

Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care

11/13/2024

David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...

David Sand, MD, MBA, chief...

11/13/2024

First Report Managed Care

Videos

The Evolving Role of CGRP-targeting Therapies in Migraine Prevention

10/31/2024

Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.

Richard Lipton, MD, provides...

10/31/2024

First Report Managed Care

Videos

Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer

09/26/2024

Alexander Spira , MD, PhD;

Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).

Alexander I. Spira, MD, PhD,...

09/26/2024

First Report Managed Care

Videos

Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives

09/25/2024

Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.

Learn about research...

09/25/2024

First Report Managed Care

Videos

Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable

09/04/2024

View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.

View a roundtable discussion on...

09/04/2024

First Report Managed Care

Videos

Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions

08/15/2024

Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...

Guest expert Jordan Bazinsky...

08/15/2024

First Report Managed Care

Videos

Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia

08/14/2024

Farrukh T. Awan , MD;

Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).

Farrukh Awan, MD, highlights...

08/14/2024

Journal of Clinical Pathways

Videos

Evolving Health Care Contact Centers Into Drivers of Value-Based Care

07/31/2024

Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.

Discover how health care contact...

07/31/2024

First Report Managed Care

Videos

Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024

06/11/2024

Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations

Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...

Key stakeholders in the health...

06/11/2024

First Report Managed Care

Melissa Andel, Principal, CommonHealth Solutions, LLC

Videos

Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers

05/24/2024

Melissa Andel, Principal, CommonHealth Solutions, LLC

Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.

Type 2 Inflammation News

Current Issue

What's Trending?

Video Insights

Subscribe to our eNewsletters!

Specialties

Events

Year Round Education

HMP Global Products